Analysts Offer Insights on Healthcare Companies: Stryker (SYK) and US Physical Therapy (USPH)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Stryker (SYK) and US Physical Therapy (USPH) with bullish sentiments.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Stryker (SYK)
Bank of America Securities analyst Travis Steed maintained a Buy rating on Stryker today. The company’s shares closed last Thursday at $305.39.
According to TipRanks.com, Steed is a 1-star analyst with an average return of
Stryker has an analyst consensus of Strong Buy, with a price target consensus of $391.67, representing a 30.0% upside. In a report issued on May 3, TipRanks – DeepSeek also upgraded the stock to Buy with a $326.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
US Physical Therapy (USPH)
In a report released today, Joanna Gajuk from Bank of America Securities maintained a Buy rating on US Physical Therapy. The company’s shares closed last Thursday at $64.46.
According to TipRanks.com, Gajuk is a 2-star analyst with an average return of
US Physical Therapy has an analyst consensus of Strong Buy, with a price target consensus of $97.50, representing a 60.2% upside. In a report issued on May 9, TipRanks – PerPlexity also upgraded the stock to Buy with a $67.00 price target.
Read More on SYK:
Disclaimer & DisclosureReport an Issue
- Stryker Shareholders Reelect Board and Approve Governance Measures
- Stryker’s Cyber Hit, Robotics Strength Dominate Earnings Call
- Stryker price target lowered to $330 from $380 at Truist
- Stryker price target lowered to $394 from $469 at Barclays
- Stryker price target raised to $361 from $357 at Goldman Sachs
